MCF7 (ER+) luminal breast cancer cells12 were treated with different chemotherapy agents, which are standard treatment in BC and had been used in the BIG 2-98 trial, and cell viability was examined by means of MTT assay. The gene discussed is ESR1; the disease is breast carcinoma.